News | Artificial Intelligence | April 16, 2019

Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite

AI-based CAD platform finds similar chest X-rays in a database with patient prioritization

Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite

April 16, 2019 — The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European languages. In addition to English, ChestEye interface now supports German, French, Spanish, Hungarian, Dutch, Czech and Lithuanian languages. The addition of multilingual support further builds on Oxipit’s strategy to increase day-to-day productivity of radiology specialists.

The company is looking to add support for more European languages based on customer requirements. The addition of extra language support usually takes from 2 to 4 weeks.

In February ChestEye suite was awarded CE certification and is available for commercial deployment in 32 European markets. It is the first AI-based full workflow medical imaging suite to be certified by a CE mark. ChestEye imaging suite encompasses a fully automatic computer aided diagnosis (CAD) platform, a search module for discovering similar-looking chest X-rays in a given database and a patient prioritization solution.

For more information: www.oxipit.ai

Related Content

RamSoft has been a proponent of the cloud since over a decade; the reason – patient data protection
News | Information Technology | November 18, 2019
November 18, 2019 — A recent report by security firm Emsisoft stated that
The study finds it's possible to use commercial facial recognition software to identify people from brain MRI that includes imagery of the face
News | Magnetic Resonance Imaging (MRI) | November 15, 2019
November 15, 2019 — Though identifying data typically are removed from medical image files before they are shared for
62-year-old woman with pure ground-glass nodules (GGN). PET/CT fusion image shows pure GGN with tumor maximum standardized uptake value of 2.8 (circle).

62-year-old woman with pure ground-glass nodules (GGN). PET/CT fusion image shows pure GGN with tumor maximum standardized uptake value of 2.8 (circle).

News | PET-CT | November 15, 2019
November 15, 2019 — According to an article published ahead-of-print in the...
EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

EchoGo uses artificial intelligence (AI) to calculate cardiac ultrasound left ventricular ejection fraction (EF), the most frequently used measurement of heart function, left ventricular volumes (LV) and, for the first time for an AI application, automated cardiac strain.

News | Cardiovascular Ultrasound | November 14, 2019
November 14, 2019 — Ultromics has received 510(k) clearance from the U.S.

Guerbet presented its Contrast&Care injection management solution at ECR 2018

News | Contrast Media | November 13, 2019
November 13, 2019 – Guerbet, a global specialist in...
 MaxQ AI
News | Artificial Intelligence | November 13, 2019
November 13, 2019 – MaxQ AI announced a new partnership agreement with...
The ALS produces various wavelengths of bright light that can be used to explore the microscopic chemistry, structure, and other properties of samples

Two researchers from Cairo University in Egypt brought 32 bone samples and two soil samples to study using X-ray and infrared light-based techniques at Berkeley Lab's Advanced Light Source (ALS). The ALS produces various wavelengths of bright light that can be used to explore the microscopic chemistry, structure, and other properties of samples. Image courtesy of Marilyn Sargent/Berkeley Lab

News | Radiology Imaging | November 13, 2019
November 13, 2019 — Experiments at the Department of Energy's Lawrence Berkeley National Laboratory (...
 Paxera Ultima 360
News | Enterprise Imaging | November 12, 2019
November 12, 2019 — Medical Imaging developer PaxeraHealth will showcase the